Back to top
Search by company, common medicine name, or title of Risk Minimisation Material
For Healthcare Professionals
The objective of this document is to provide guidance to healthcare professionals for the management of patients receiving Fabrazyme (agalsidase beta) at home. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
For Healthcare Professionals
The objective of this document is to provide patients with guidance on how to receive Fabrazyme (agalsidase beta) at home. It is the responsibility of the treating physician to supply this material to patients only if the treating physician decides that the patient is eligible for home infusion treatment. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
For Healthcare Professionals
Combined Hormonal Contraceptives - checklist for prescribers
Combined hormonal contraceptives: Q&As about the important information for women.
Important Information for women about risk of blood clots with combined hormonal contraceptives.
For Healthcare Professionals
Combined Hormonal Contraceptives - checklist for prescribers
Combined hormonal contraceptives: Q&As about the important information for women.
Important Information for women about risk of blood clots with combined hormonal contraceptives.
For Healthcare Professionals
Combined Hormonal Contraceptives - checklist for prescribers
Combined hormonal contraceptives: Q&As about the important information for women.
Important Information for women about risk of blood clots with combined hormonal contraceptives.
For Healthcare Professionals
The Fenhuma™ Prescriber Guide is designed to support healthcare professionals in the diagnosis of breakthrough pain (BTP) in patients suffering from cancer. It provides guidance on the initiation, administration and titration of Fenhuma™ and promotes engagement with patients and their carers. The booklet should be used in conjunction with the Fenhuma™ Summary of Product Characteristics (SPC).
Booklet for patients that have been prescribed Fenhuma. It contains important information for patients and their carers including what is breakthrough cancer pain, what is Fenhuma, how does Fenhuma work, how to take Fenhuma the right way, adverse effects which might be experienced, requirements for storing Fenhuma and frequently asked questions.
For Healthcare Professionals
Dissemination of educational materials for Fingolimod SUN Communication plan
For Healthcare Professionals
Fingolimod SUN Prescriber’s checklist Important points to remember before, during and after treatment
For Healthcare Professionals
Important things to remember about Fingolimod SUN treatment for patients, parents and caregivers
For Healthcare Professionals
Fingolimod SUN Pregnancy-Specific Patient Reminder Card
This patient booklet contains important things to remember about Fingolimod treatment for patients, parents and caregivers
This reminder card contains pregnancy-specific safety information about Fingolimod treatment
For Healthcare Professionals
This checklist outlines important points to remember before, during and after treatment
Pregnancy-specific patient reminder card for those on fingolimod treatment
Important things to remember about Fingolimod treatment for patients, parents and caregivers
For Healthcare Professionals
This checklist outlines important points to remember before, during and after treatment
Fingolimod Patient and Caregivers Guide - Important things to remember about Fingolimod treatment for patients, parents and caregivers
Fingolimod Pregnancy-specific patient reminder card
For Healthcare Professionals
Fingolimod prescriber’s checklist Important points to remember before, during and after treatment
Important things to remember about Fingolimod Zentiva 0.5 mg hard capsules treatment for patients, parents and caregivers
Fingolimod patient information-Pregnancy-Specific Patient Reminder Card
Important things to remember about Fingolimod treatment for patients, parents and caregivers
Fingolimod Pregnancy-specific patient reminder card
For Healthcare Professionals
Fingolimod Prescriber’s Checklist – Important points to remember before, during and after treatment
Important things to remember about Fingolimod treatment for patients, parents and caregivers
For Healthcare Professionals
For HCPs: Important points to remember before, during and after treatment with Fingolimod
Pregnancy-Specific Patient Reminder Card for Fingolimod
Fingolimod Pregnancy-Specific Patient Reminder Card Reminder card Pregnancy-Specific for patients that have been prescribed fingolimod. It contains information on before starting fingolimod treatment, while you are taking fingolimod and after stopping fingolimod treatment.
Booklet for patients that have been prescribed fingolimod. It contains important information for patients, parents and caregivers including what is multiple sclerosis(MS), how does Fingolimod work, how to take fingolimod the right way and why monitoring your treatment is important.
For Healthcare Professionals
The checklist is intended to assist in the management of patients on fingolimod. Key steps and considerations while starting, continuing, or discontinuing treatment are provided.
For Healthcare Professionals
Fingolimod Teva Prescriber's Checklist
This guide contains information about the risks associated with FINTEPLA and the tests and checks that are needed during treatment with fenfluramine.
For Healthcare Professionals
This guide is developed to increase awareness and educate prescribers about the risks associated with the use of Fintepla and to inform the prescribing physicians of the need to conduct periodic cardiac monitoring in patients taking Fintepla.
This Reminder Card contains important safety information that patients need to be aware of before and during treatment with Flixabi.
Are you a healthcare professional?
Are you a healthcare professional?
Skip to main content